Texas · 89th Legislature (2025) · Bill
HB 3057: Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.
Enacted Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 3057 is a bill introduced in the Texas House on February 19, 2025. According to its official title, it concerns: Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy. Primary sponsor: Brooks Landgraf (Republican), Kevin Sparks (Republican). It lists 1 additional sponsor. Most recent recorded action (June 20, 2025): Effective on 9/1/25.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Brooks Landgraf | Primary sponsor | Republican | House | 81 |
| Kevin Sparks | Primary sponsor | Republican | Senate | 31 |
| Adam Hinojosa | Co-sponsor | Republican | Senate | 27 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Effective on 9/1/25
- Signed by the Governor
- Sent to the Governor
- Signed in the Senate
- Signed in the House
- Reported enrolled
- Senate passage reported
- Placed on local & uncontested calendar
- Record vote
- Passed
- Read 3rd time
- Record vote
Showing 12 most recent of 40 actions. Full history